LEXX
NASDAQ
$0.60
Lexaria Bioscience Corp (LEXX)
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $3.50 (+483.33%)
Market Cap
$15M
FCF 5Y CAGR
+21.42%
Free Cash Flow Yield
-51.22%
Beta (5Y)
0.95
Price Chart
Valuation
Market Cap$15M
P/S75.14
P/B3.07
Profitability
Total Revenue (TTM)$194K
Gross Profit (TTM)$194K
EBITDA-$7.65M
Operating Margin-3863%
EPS-$0.35
Financial Health
Free Cash Flow Yield-51.22%
Growth & Risk
EPS 5Y CAGR-16.62%
Revenue 5Y CAGR-18.03%
FCF 5Y CAGR+21.42%
Beta (5Y)0.95
Sharpe Ratio0.16